Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albuferon + Ribavirin in Interferon-Experienced Chronic Hepatitis C
NCT00097435Phase 2Completed
- Sponsor
- Human Genome Sciences
- Start
- Oct 2004
- Primary completion
- Aug 2007
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of albinterferon alfa-2b in hepatitis C (HCV), sponsored by Human Genome Sciences. Started Oct 2004; status: completed.
02
Drugs
albinterferon alfa-2b
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00097435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00097435.